ATE223046T1 - Pufferzusammensetzung fur immunologische reagenzien - Google Patents

Pufferzusammensetzung fur immunologische reagenzien

Info

Publication number
ATE223046T1
ATE223046T1 AT96916655T AT96916655T ATE223046T1 AT E223046 T1 ATE223046 T1 AT E223046T1 AT 96916655 T AT96916655 T AT 96916655T AT 96916655 T AT96916655 T AT 96916655T AT E223046 T1 ATE223046 T1 AT E223046T1
Authority
AT
Austria
Prior art keywords
composition
buffer composition
buffer
immunological reagents
biological
Prior art date
Application number
AT96916655T
Other languages
English (en)
Inventor
Steve D Figard
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE223046T1 publication Critical patent/ATE223046T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/82Hepatitis associated antigens and antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/826Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
AT96916655T 1995-06-07 1996-05-24 Pufferzusammensetzung fur immunologische reagenzien ATE223046T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/482,710 US5616460A (en) 1995-06-07 1995-06-07 Buffer composition for reagents for immunoassay
PCT/US1996/007745 WO1996041164A1 (en) 1995-06-07 1996-05-24 Buffer composition for reagents for immunoassay

Publications (1)

Publication Number Publication Date
ATE223046T1 true ATE223046T1 (de) 2002-09-15

Family

ID=23917128

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916655T ATE223046T1 (de) 1995-06-07 1996-05-24 Pufferzusammensetzung fur immunologische reagenzien

Country Status (7)

Country Link
US (2) US5616460A (de)
EP (1) EP0852009B1 (de)
JP (2) JP4101874B2 (de)
AT (1) ATE223046T1 (de)
DE (1) DE69623303T2 (de)
ES (1) ES2184866T3 (de)
WO (1) WO1996041164A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991790B1 (en) 1997-06-13 2006-01-31 Genentech, Inc. Antibody formulation
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
IL133220A0 (en) * 1997-06-13 2001-03-19 Genentech Inc Stabilized antibody formulation
ATE417275T1 (de) * 1997-09-22 2008-12-15 Novartis Vaccines & Diagnostic Puffern zur stabilizierung von hcv antigenen
EP1021719B1 (de) 1997-09-22 2007-02-21 Novartis Vaccines and Diagnostics, Inc. Verfahren zum nachweiss von antikörpern in einer probe
CA2324970C (en) * 1998-04-17 2009-06-30 Innogenetics N.V. Improved immunodiagnostic assays using reducing agents
EP1020727B1 (de) 1998-07-30 2008-10-29 Advanced Life Science Institute, Inc. Verfahren zur bestimmung von hepatitis c viren
US6623921B2 (en) 1998-07-30 2003-09-23 Advanced Life Science Institute, Inc. Method for measurement of hepatitis C virus
DE10013794A1 (de) * 2000-03-15 2001-10-11 Gluesenkamp Karl Heinz Herstellung, Stabilisierung und Anwendung einer neuen Art von chemisch aktivierten Oberflächen
AU2001273264A1 (en) * 2000-07-21 2002-02-05 Cuno, Incorporated Improved blocking chemistries for nylon membrane
CA2419295A1 (en) * 2000-08-21 2002-02-28 Queen's University At Kingston Methods and kits for separation and detection of proteins in biological samples
US20030170618A1 (en) * 2001-02-02 2003-09-11 Chien David Y. Buffers for stabilizing antigens
AU785380B2 (en) * 2001-03-28 2007-03-15 Ortho-Clinical Diagnostics, Inc. A hepatitis C antigen - antibody combination assay for the early detection of HCV infection
JP2003066047A (ja) * 2001-06-14 2003-03-05 Matsushita Electric Ind Co Ltd 免疫反応測定方法及びそれに用いる免疫反応測定用試薬
US7101683B2 (en) 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
CH698246B1 (de) * 2001-12-20 2009-06-30 Hoffmann La Roche Test zur Identifizierung von Inhibitoren von Beta-Sekretasen.
US20030157556A1 (en) * 2002-02-13 2003-08-21 Maggiore Jack A. Biological fluid stabilizing composition and method of use thereof
AU2003238767A1 (en) * 2002-05-31 2003-12-19 Penn State Research Foundation Dot-elisa for the detection of animal viruses
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
US20050014136A1 (en) * 2003-05-28 2005-01-20 Innogenetics N.V. Modified HCV NS5
CN101892199A (zh) * 2003-10-28 2010-11-24 株式会社先端生命科学研究所 丙型肝炎病毒的检测方法
WO2005083433A1 (en) * 2004-02-26 2005-09-09 Candor Bioscience Gmbh An aqueous solution for use as medium for the specific binding reaction of a binding pair
CN104090097B (zh) * 2004-02-26 2017-04-12 康多尔生物技术有限公司 一种用作结合对的特异性结合反应培养基的水溶液
US7867443B2 (en) * 2004-07-23 2011-01-11 Dako Denmark A/S Method and apparatus for automated pre-treatment and processing of biological samples
US20080108147A1 (en) * 2006-11-03 2008-05-08 Tie Wei Reduction of non-specific binding in immunoassays
JP2007084579A (ja) * 2006-12-28 2007-04-05 Mitsubishi Pharma Corp ヘパリン溶液入りプレフィルドシリンジ製剤およびその製造方法
US8617820B2 (en) * 2007-08-28 2013-12-31 Ortho-Clinical Diagnostics, Inc. Use of glycosaminoglycans to reduce non-specific binding in immunoassays
JP5416159B2 (ja) * 2011-03-31 2014-02-12 富士フイルム株式会社 高感度なイムノクロマトグラフ方法
CN103630690B (zh) * 2013-12-17 2014-08-20 朱之炜 丙型肝炎病毒抗原抗体联合检测试剂盒及其检测方法
EP3258270B1 (de) * 2015-02-10 2019-05-29 Shenzhen New Industries Biomedical Engineering Co. Ltd. Ultrasensitives reagenzienkit zum nachweis von kardialem troponin i und ultraempfindliches nachweisverfahren dafür
CN114200125B (zh) * 2021-12-06 2024-02-13 武汉生之源生物科技股份有限公司 一种不含蛋白的碱性磷酸酶-抗体偶联物稀释液及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59198999A (ja) * 1983-04-27 1984-11-10 Denka Seiken Co Ltd クレアチンキナ−ゼ測定用組成物
JPS6339582A (ja) * 1986-08-04 1988-02-20 Takara Shuzo Co Ltd 酵素組成物
US4956274A (en) * 1987-04-06 1990-09-11 Microgenics Corporation Reagent stabilization in enzyme-donor and acceptor assay
US5075221A (en) * 1988-10-07 1991-12-24 Eastman Kodak Company Stabilized extraction composition containing a sulfhydryl-containing reducing agent and its use in chlamydial and gonococcal determinations
KR910700061A (ko) * 1988-12-06 1991-03-13 오스카 아끼히꼬 인터로이킨-1β의 안정화 조성물
EP0527815B1 (de) * 1990-04-06 2000-07-19 Genelabs Technologies, Inc. Hepatitis c-virus-epitope
WO1993006247A1 (en) * 1991-09-16 1993-04-01 Abbott Laboratories Hepatitis c assay
US5376313A (en) * 1992-03-27 1994-12-27 Abbott Laboratories Injection molding a plastic assay cuvette having low birefringence
GR1001480B (el) * 1992-12-29 1994-02-28 Eyaggelia Protopapa Ενζυμικά σκευάσματα περιέχοντα παπαϊνη ή χυμο?ρυψίνη και μέ?οδοι μόνιμης ενζυμικής αποτρίχωσης.

Also Published As

Publication number Publication date
JP3930519B2 (ja) 2007-06-13
DE69623303D1 (de) 2002-10-02
JP4101874B2 (ja) 2008-06-18
EP0852009A1 (de) 1998-07-08
ES2184866T3 (es) 2003-04-16
EP0852009B1 (de) 2002-08-28
US5616460A (en) 1997-04-01
JP2001516440A (ja) 2001-09-25
JP2005300552A (ja) 2005-10-27
WO1996041164A1 (en) 1996-12-19
DE69623303T2 (de) 2003-04-17
US5773212A (en) 1998-06-30

Similar Documents

Publication Publication Date Title
DE69623303D1 (de) Pufferzusammensetzung fur immunologische reagenzien
KR840005083A (ko) 항고혈압제로서 유용한 아미노산유도체의 제조방법
JPS646861A (en) Chromogen cryptahemispherand and use thereof for detection of electrolyte in water inspection sample
NO930770L (no) Immunologisk fremgangsmaate for bestemmelse av et hemoglobinderivat
IE891182L (en) Compositions, diagnostic kit and method for rapid detection¹of antibodies
SE7905009L (sv) Ny l-gamma-glutamyl-3-karboxi-4-hydroxianilid och salter derav
ES2036566T3 (es) Solucion conteniendo cloruro de lisocima y gliciricinato dipotasico.
NO871663L (no) Adhesiver avledet fra bioadhesive polyfenoliske proteiner.
KR900015612A (ko) 글루타르알데하이드와 1,2-벤즈이소티아졸린-3-온의 수성 농축 용액
NO895002L (no) Enzymhemmende aminosyrederivater.
TR27442A (tr) Sivi asindirici temizleme terkibi.
CA2221556A1 (en) Buffer composition for reagents for immunoassay
ES2015068B3 (es) Nuevos derivados sustituidos de n-etil(met) acrilamina y procedimiento para su preparacion.
ES2174858T3 (es) Procedimiento para determinar el contenido de fructosamina.
KR850001291A (ko) 폴리에테르 항생물질 x-14934a의 제조방법
AU6520196A (en) Aqueous compositions containing ciprofloxacine, and related use and process
KR910000746A (ko) 1, 1-디옥소페닐실리노일 옥시메틸 d-6-[x-(메틸렌 아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
ATE221730T1 (de) Enzym-konzentrat
KR870006024A (ko) 니자티딘의 제조방법
AU3577295A (en) Reagent for the determination of free radicals
FR2376864A1 (fr) Reactif et procede de determination du cholecalciferol
DE3662048D1 (de) Novel thyronine derivatives
KR920019742A (ko) L-프롤린 유도체의 제조방법
KR840000482A (ko) 시스틴 유도체의 제조방법
KR890015021A (ko) 칼슘분석시약

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0852009

Country of ref document: EP

REN Ceased due to non-payment of the annual fee